Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drotaverine for Shortening Labor in Nulliparous Women
NCT01639027Phase 3Completed
- Sponsor
- Ain Shams University Maternity Hospital
- Start
- May 2012
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in labor comparing Drotaverine with Placebo (2 arms). Primary endpoint: Duration of the active first stage of labor at 12 hours. Started May 2012; status: completed.
02
Drugs
drotaverine
03
Conditions
labor
Beyond the preview
Go deeper on NCT01639027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01639027.